Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells

Open Access

Peer-reviewed

Research Article

Peter S. Fenwick,

Affiliation Airway Disease, National Heart and Lung Institute, Imperial College London, London, United Kingdom
⨯
Patricia Macedo,

Affiliation Airway Disease, National Heart and Lung Institute, Imperial College London, London, United Kingdom
⨯
Iain C. Kilty,

Affiliation Pfizer Inc, Cambridge, Massachusetts, United States of America
⨯
Peter J. Barnes,

Affiliation Airway Disease, National Heart and Lung Institute, Imperial College London, London, United Kingdom
⨯
Louise E. Donnelly

* E-mail: l.donnelly@imperial.ac.uk

Affiliation Airway Disease, National Heart and Lung Institute, Imperial College London, London, United Kingdom
⨯

Reader Comments (0)

Epithelial cells
Is the Subject Area "Epithelial cells" applicable to this article?

Thanks for your feedback.
Chronic obstructive pulmonary disease
Is the Subject Area "Chronic obstructive pulmonary disease" applicable to this article?

Thanks for your feedback.
Chemokines
Is the Subject Area "Chemokines" applicable to this article?

Thanks for your feedback.
Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
DNA transcription
Is the Subject Area "DNA transcription" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Inflammatory diseases
Is the Subject Area "Inflammatory diseases" applicable to this article?

Thanks for your feedback.